International Business News - Health http://www.ibtimes.com/rss/feed/health.rss All articles are copyrighted by IBTimes.com 120 30 http://www.ibtimes.com/rss/feed/health.rss http://www.ibtimes.com/images/top_logo_ibt2_3.gif Britain's Shire has asked the EU to officially allow people to take its new Gaucher disease drug, it said on Tuesday, providing hope to sufferers of the disease as supplies of a rival drug start to run out. http://www.ibtimes.com/articles/20091124/shire-asks-eu-gaucher-drug-approval.htm http://www.ibtimes.com/data/articleimgs/224646-shire-asks-eu-for-gaucher-drug-approval.jpg http://www.ibtimes.com/articles/20091124/shire-asks-eu-gaucher-drug-approval.htm http://www.ibtimes.com/articles/20091124/shire-asks-eu-gaucher-drug-approval.htm Tue, 24 Nov 2009 11:37:34 EST Spectrum Pharmaceuticals Inc said Handok Pharmaceuticals Co Ltd will develop and commercialize Spectrum's experimental cancer drug in South Korea as part of a deal valued at more than $19 million. http://www.ibtimes.com/articles/20091123/spectrum-inks-deal-with-koreas-handok-cancer-drug.htm http://www.ibtimes.com/articles/20091123/spectrum-inks-deal-with-koreas-handok-cancer-drug.htm Mon, 23 Nov 2009 10:55:12 EST Healthcare information and services provider HealthPort Inc's bid for an initial public offering was withdrawn on Thursday morning before the markets opened, according to a source familiar with the deal. http://www.ibtimes.com/articles/20091119/healthport-ipo-withdrawn-source.htm http://www.ibtimes.com/articles/20091119/healthport-ipo-withdrawn-source.htm Thu, 19 Nov 2009 11:36:53 EST Medical device maker China Medical Technologies Inc posted a quarterly loss, hurt by lower revenue from its immunodiagnostic segment, knocking its shares down 19 percent. http://www.ibtimes.com/articles/20091119/china-medical-technologies-posts-q2-loss-shrs-fall.htm http://www.ibtimes.com/articles/20091119/china-medical-technologies-posts-q2-loss-shrs-fall.htm Thu, 19 Nov 2009 11:27:15 EST Amil Participacoes, Brazil's largest provider of supplemental health services, agreed on Thursday to buy control of rival Medial Saude to expand in the country's wealthiest state and cut operating costs. http://www.ibtimes.com/articles/20091119/brazils-amil-buy-52-pct-medial-354-mln.htm http://www.ibtimes.com/articles/20091119/brazils-amil-buy-52-pct-medial-354-mln.htm Thu, 19 Nov 2009 11:17:41 EST German generic drugmaker Ratiopharm has attracted at least 10 first-round bids, several people familiar with the procedure told Reuters on Wednesday, indicating that a competitive auction was underway. http://www.ibtimes.com/articles/20091111/least-10-bids-filed-ratiopharm-sale-sources.htm http://www.ibtimes.com/articles/20091111/least-10-bids-filed-ratiopharm-sale-sources.htm Wed, 11 Nov 2009 13:15:36 EST Contract electronics maker Celestica Inc is examining 14 companies in the healthcare industry as possible acquisition targets, its chief executive said on Tuesday. http://www.ibtimes.com/articles/20091110/celestica-seeks-healthcare-acquisitions-ceo.htm http://www.ibtimes.com/articles/20091110/celestica-seeks-healthcare-acquisitions-ceo.htm Tue, 10 Nov 2009 11:11:33 EST Chindex International Inc, a provider of western healthcare products and services in China, posted a 38 percent drop in quarterly profit, hurt by a review of import approvals by the Chinese government, sending its shares down as much as 28 percent. http://www.ibtimes.com/articles/20091109/chindex-posts-lower-q2-profit-shares-sink.htm http://www.ibtimes.com/articles/20091109/chindex-posts-lower-q2-profit-shares-sink.htm Mon, 09 Nov 2009 11:44:41 EST Austrian biotech company Intercell scrapped its full-year profit target after third-quarter revenue for its Ixiaro vaccine against Japanese Encephalitis fell short of expectations. http://www.ibtimes.com/articles/20091109/intercell-eyes-fy-loss-on-weak-vaccine-sales.htm http://www.ibtimes.com/articles/20091109/intercell-eyes-fy-loss-on-weak-vaccine-sales.htm Mon, 09 Nov 2009 11:38:57 EST Smith & Nephew beat forecasts for the third quarter as patients and governments began to resume spending on surgical procedures after cutting back during the recession. http://www.ibtimes.com/articles/20091106/smith-nephew-q3-beats-hopes-sees-mkt-stabilising.htm http://www.ibtimes.com/articles/20091106/smith-nephew-q3-beats-hopes-sees-mkt-stabilising.htm Fri, 06 Nov 2009 04:12:23 EST Private equity firm TPG and the Canada Pension Plan struck on Thursday the biggest leveraged buyout deal of this year, worth $4 billion, to buy prescription drug sales data provider IMS Health Inc. http://www.ibtimes.com/articles/20091105/ims-agrees-tobln-deal-biggest-lbo.htm http://www.ibtimes.com/articles/20091105/ims-agrees-tobln-deal-biggest-lbo.htm Thu, 05 Nov 2009 13:41:26 EST CareFusion Corp, the medical device company spun off from Cardinal Health on Sept. 1, posted a higher-than-expected quarterly profit, driven by strong demand in ventilators for flu and emergency preparedness related to H1N1, or swine flu. http://www.ibtimes.com/articles/20091105/carefusion-beats-street-raises-outlook-shrs-jump.htm http://www.ibtimes.com/articles/20091105/carefusion-beats-street-raises-outlook-shrs-jump.htm Thu, 05 Nov 2009 10:59:15 EST TPG and the Canada Pension Plan on Thursday announced a deal to buy IMS Health Inc hich provides prescription drug sales data, for around $4 billion. http://www.ibtimes.com/articles/20091105/tpg-canada-pension-agree-tobln-ims-buyout.htm http://www.ibtimes.com/articles/20091105/tpg-canada-pension-agree-tobln-ims-buyout.htm Thu, 05 Nov 2009 10:53:11 EST Watson Pharmaceuticals Inc posted lower net income on Wednesday, as the generic drugmaker added spending to launch two brand-name medicines and saw lower revenue from its distribution unit. http://www.ibtimes.com/articles/20091104/watson-pharma-third-quarter-net-profit-falls.htm http://www.ibtimes.com/articles/20091104/watson-pharma-third-quarter-net-profit-falls.htm Wed, 04 Nov 2009 10:57:28 EST Aviv REIT Inc, a real estate investment trust that focuses on healthcare properties, postponed its initial public offering, which had been scheduled to price on Tuesday, according to one of the company's underwriters. http://www.ibtimes.com/articles/20091104/aviv-reit-ipo-postponed.htm http://www.ibtimes.com/articles/20091104/aviv-reit-ipo-postponed.htm Wed, 04 Nov 2009 10:52:53 EST Merck & Co and Schering-Plough Corp said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm http://www.ibtimes.com/data/articleimgs/223440-merck-schering-plough-set-to-complete-merger.jpg http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm http://www.ibtimes.com/articles/20091104/merck-schering-plough-set-complete-merger.htm Wed, 04 Nov 2009 10:38:50 EST Human Genome Sciences Inc said its experimental lupus drug Benlysta was successful in a late-stage clinical trial, paving the way for approval of the first new treatment for the disease in 50 years. http://www.ibtimes.com/articles/20091102/human-genome-glaxo-lupus-drug-works-in-2nd-trial.htm http://www.ibtimes.com/articles/20091102/human-genome-glaxo-lupus-drug-works-in-2nd-trial.htm Mon, 02 Nov 2009 12:08:01 EST Valeant Pharmaceuticals International posted a better-than-expected quarterly profit, helped by higher revenue from its specialty pharmaceutical segment, and raised its 2009 earnings view. http://www.ibtimes.com/articles/20091102/valeant-q3-beats-estimates-raises-09-profit-view.htm http://www.ibtimes.com/articles/20091102/valeant-q3-beats-estimates-raises-09-profit-view.htm Mon, 02 Nov 2009 10:11:02 EST Hospital products and generic drugmaker Hospira Inc on Tuesday said quarterly net earnings rose 42 percent, fueled by a new product launch, and it raised its full-year profit forecast. http://www.ibtimes.com/articles/20091027/hospira-q3-tops-estimates-boosts-outlook.htm http://www.ibtimes.com/articles/20091027/hospira-q3-tops-estimates-boosts-outlook.htm Tue, 27 Oct 2009 10:57:57 EDT U.S. drugmaker Merck & Co Inc's $41.1 billion takeover of smaller rival Schering-Plough Corp won approval from European Union antitrust regulators on Friday. http://www.ibtimes.com/articles/20091023/merck-takeover-schering-plough-wins-eu-approval.htm http://www.ibtimes.com/data/articleimgs/222889-merck-takeover-of-schering-plough-wins-eu-approval.jpg http://www.ibtimes.com/articles/20091023/merck-takeover-schering-plough-wins-eu-approval.htm http://www.ibtimes.com/articles/20091023/merck-takeover-schering-plough-wins-eu-approval.htm Fri, 23 Oct 2009 11:05:36 EDT